Cash injection: sovereign funds target healthcare:
"Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates. Rather than science fiction, these are examples of cutting-edge research being pioneered by biotech firms seeking to revolutionize healthcare from cradle to grave. Such work tends to be highly expensive and can take years to pay off -- which makes it a good fit for deep-pocketed sovereign wealth and pension funds that can afford to tie up capital for a long time."
'via Blog this'
No comments:
Post a Comment